Skip to content
Riskpilot
← Back to search
Sign in
Get full access
STIFTELSEN NORSK REVMATIKER- FORBUNDS FORSKNINGSFOND
STI
Active
Org 974536080
Professor Dahls gate 32, 0260
Oslo
Activities of other membership organisations n.e.c.
· NACE 9499
Est. 1995 · 31 years old
0 employees
www.revmatiker.no
Monitor
Share
Norway
/
Companies
/
Activities of other membership organisations n.e.c.
/
STIFTELSEN NORSK REVMATIKER- FORBUNDS FORSKNINGSFOND
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (6)
ML
May Liz Lindsetmo Bestvold
Deputy Member
Deputy Member
2024
ID
Ingeborg Dybvig
Chief Executive Officer
Chief Executive Officer
2025
HB
Hilde Berner Hammer
Deputy Member
Deputy Member
2021
ER
Eva Rønningen
Deputy Member
Deputy Member
2024
HK
Hanne Katrine Schjerverud
Deputy Member
Deputy Member
2021
UG
Ulf Gunnar Sundin
Deputy Member
Deputy Member
2024
Former (6)
MM
Marianne Molin
Deputy Member
Deputy Member
2021 – 2024
JH
Jan Halvard Relbe-Moe
Deputy Member
Deputy Member
2021 – 2024
MA
May-Brit Askestrand
Chief Executive Officer
Chief Executive Officer
2025 – 2025
BA
Bo Alexander Burden Gleditsch
Chief Executive Officer
Chief Executive Officer
2021 – 2025
AM
Anne Marie Smeplass
Deputy Member
Deputy Member
2021 – 2024
LB
Lina Bjelland
Chief Executive Officer
Chief Executive Officer
2021 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
SE
Stine Elisabeth Wasenius Dahl
Chairman
2024
MS
Mads Sundet
Board of Directors
2024
MM
Marleen Margarete Rones
Board of Directors
2024
EA
Espen Andre Haavardsholm
Board of Directors
2021
JS
Joachim Støren Sagen
Board of Directors
2021
Former (3)
LA
Linda Aimée Hartford Kvæl
Board of Directors
2021 – 2024
ML
Mona Larsen
Chairman
2021 – 2024
TE
Tor Eivind Johansen
Board of Directors
2021 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on STIFTELSEN NORSK REVMATIKER- FORBUNDS FORSKNINGSFOND
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network